TL;DR: Helix North ships domestically within Canada, publishes third-party Certificates of Analysis on relevant product pages where held, and stocks a deliberately narrow catalog rather than a long tail of poorly characterized compounds. For the full range see our Canadian research peptides page; this is the shorter story behind it.

The operation rests on three commitments: domestic shipping, verified purity, and a catalog matched to what Canadian researchers actually use. We are based in Canada, ship only within Canada, and built the business around that constraint rather than treating it as a limitation.

Why Domestic Shipping Matters

Cross-border research peptide shipments add three costs, only one of which is money.

  • Customs uncertainty. A shipment can be held, inspected, or returned with no warning and no recourse. For a protocol already underway, an indefinite hold is worse than a slow delivery.
  • Time. International transit plus customs processing turns days into weeks, unpredictably.
  • Currency and brokerage. Exchange rates and brokerage fees mean the price quoted is rarely the price paid.

A domestic supplier holding stock removes all three. Orders ship anywhere in Canada by Canada Post Xpresspost — flat $30 CAD to any postal code, tracked, in plain packaging. Typical transit is 2 to 4 business days to Ontario and Quebec, 2 to 3 to the Prairies, and 1 to 2 in British Columbia. Pricing is in Canadian dollars, so the number on the product page is the number on the receipt.

Purity and Verification

Every lot is sent to an independent third-party laboratory for HPLC purity analysis, with identity confirmed by mass spectrometry. We do not release a lot below 99 percent purity.

Where we hold one, the Certificate of Analysis is published on the relevant product page — lot number, chromatogram, and calculated purity — rather than furnished on request after an order. Not every catalog product has a published CoA. The distinction matters: verification you can review before buying is a different thing from verification you are told exists.

Almost every peptide supplier claims third-party testing. Far fewer publish the actual certificates where a prospective customer can read them first.

Our lab testing and CoA page covers the methodology and what each section of a certificate actually tells you.

A Deliberately Focused Catalog

The catalog covers the compound classes most actively studied in current peptide research: GLP-1 receptor agonists including dual and triple agonists, tissue-repair peptides, mitochondrial peptides, growth hormone secretagogues, nootropics, and metabolic small molecules.

What it deliberately excludes is the long tail — compounds with thin literature that exist in catalogs mainly to make the catalog look larger. Stocking fewer compounds means each one can be sourced, verified, and restocked properly. A supplier listing two hundred compounds is not verifying two hundred compounds with equal care.

For the current range, see the GLP research hub, BPC-157, retatrutide, or the full catalog.

What We Deliberately Do Not Do

Worth stating plainly, because the omissions are as intentional as the inclusions.

We do not publish dosing schedules, administration protocols, or clinical recommendations for any compound. We do publish reconstitution mechanics — concentration math, syringe-unit conversion, storage and stability — because those are laboratory procedures rather than human-use guidance. Our peptide reconstitution calculator and storage guide exist for that purpose.

We also do not make therapeutic claims. Most compounds in this catalog have no completed human trials, and where the evidence is preclinical our writing says so.

All products are sold strictly for research purposes only. Not for human consumption. Helix North products are intended for laboratory and in-vitro applications by qualified researchers.

Get In Touch

Questions about specific compounds, bulk pricing, or CoA documentation? Reach us through the contact form and we will respond within one business day.